TP53 and myeloid sarcoma: Although specific genetic alterations have been associated with these molecular subtypes, EGFR gene alterations to CL, TP53 and PDGFRA gene alterations PN, and NF1 gene alterations to MS, the MS profile appears to represent a worsening evolution of the other three [20].